Questions from patients and their relatives streamed in to a recent Centers for Disease Control and Prevention (CDC) conference call for clinicians about the ongoing outbreak of rare fungal infections linked to contaminated steroids from the New England Compounding Center (NECC), a compounding pharmacy in Framingham, Mass.
The outpouring of frustration and fear, during a briefing that would typically be dominated by clinicians' discussion of the management of the condition, was unprecedented. But the unexpected is becoming routine for physicians and public health authorities grappling with an epidemic that continues to disrupt lives and challenge clinical knowledge.
Kuehn BM. Patients Given Fungus-Tainted Injections Continue to Face Uncertainty, Illness. JAMA. 2013;309(16):1669-1670. doi:10.1001/jama.2013.3616